Skip to main content
Loading ResearchHub…
Cited by — Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis | ResearchHub - ResearchHub